~" One hundred eighty of 207 consecutive patients with ventricular shunts were studied to determine the incidence of post-shunt epilepsy. Of these 17 (9.4%) developed seizures. The incidence fell from 15.2% in children younger than 1 year to 6.9% in patients over 50 years of age, but age was not statistically significant. Of patients with a parietal ventricutar catheterization site only 6.6% had convulsions, in contrast to 54.5% of those with a frontal locus. The incidence of seizures rose with multiple ventricular catheter revisions, but was unrelated to bilaterality of shunting. The risk of seizures fell from 5% in the 1st year after shunting to 1.1% after the 3rd year.
C
EREBROSPINAL fluid (CSF) diversion by ventricular shunting is widely regarded as a routine procedure. We believe that identification and minimization of complications are more important when a procedure assumes the mantle of the commonplace. A shunt failure may be mechanical, biological, or technical; however, with ventricular shunts penetration of the cortical mantle is inevitable and this may lead to the complication of epilepsy. Relatively few studies of epilepsy after ventricular shunting have been published, and the reported incidence varies widely, ranging from 48% of 26 cases documented by Graebner and Celesia, 4 to 24% of the 78 patients described by Copeland, et al.,2 and 18 % of the 33 cases of Marossero, et al. 7 
Clinical Material and Methods
We examined the records of 207 consecutive patients who were identified as having a ventricular shunt either inserted for the first time or revised between 1972 and 1981 at Concord Hospital, the Mater Hospital, or St. Margaret's Children's Hospital, Sydney. Twenty-seven patients were found to have had seizures prior to insertion of the first ventricular shunt and were excluded from the study. The remaining 180 met our criterion of a minimum follow-up period of 2 years unless they died during the 2nd year after the first shunting procedure. Thus, 27 patients (15%) were followed for 1 to 2 years, 99 (55%) for 2 to 5 years, 46 (25.6%) for 6 to 9 years, and eight (4.4%) were followed for 10 years or longer. The longest follow-up period was 16 years from the first ventricular shunting procedure. The group consisted of 117 males and 63 females. This 65% male preponderance is explained by the large number of military and veteran personnel in the study. The veterans in the study biased the age distribution which extended from neonates to 70 years with a mean age of 38.2 years ( Table 1) .
As it seemed probable to us that cortical injury was the most important factor in the development of epilepsy, we examined the number of ventricular revisions, the use of bilateral ventricular catheters, and the anatomical site of the ventricular catheters. The surgical technique was the same for both frontal and parietal catheterizations, and no technical differences in handling the cortex between these sites could be identified. The dura was cauterized after the cranial opening and the cerebral cortex was cauterized locally; then a cortical incision was made with a scalpel. The ventricle was tapped with a brain needle before passage of the ventricular catheter along the path of the brain needle.
Prophylactic anticonvulsant drugs were not routinely used. They were used either when the surgeon was concerned that the patient was at risk from the underlying disorder or when the patient had already commenced anticonvulsant therapy prior to referral to neurosurgery. In all cases the anticonvulsant agent administered was phenytoin sodium. The data in this study were analyzed using the chisquare test. For assessment of the data regarding the anatomical position of the shunt, Yates' correction was applied.
Results
None of the study group had experienced seizures prior to shunt placement. Of the study group, 17 (9.4%) had postoperative convulsions. While the underlying disorder must affect the risk of epilepsy, no pattern emerged among these 17 patients (Table 2 ). There was an age gradation (Table 1) falling from 15.2% in children aged less than 1 year to 2.9% of those aged over 5 years, but this did not reach statistical significance (p = 0.1).
A total of 108 shunt revisions were performed in 61 patients. No patient in this study had more than three revisions of the ventricular catheter. Revision frequency had a significant relationship to the occurrence of seizures (p = 0.05), as only 5.9% of those who did not have a catheter revision developed epilepsy, compared with 24.2% of those with two or more ventricular catheter revisions (Table 3) . Of the 160 patients (88%) who had a unilateral ventricular catheter inserted, 15 (9.4%) developed epilepsy. Two of the 21 patients with bilateral ventricular catheters developed seizures, for an almost identical incidence of 9.5%.
A significant factor (p = 0.01) in our study was the anatomical site of cortical puncture for ventricular catheterization. We selected a posterior parietal locus for catheter insertion in 168 patients. Ten (6.6%) of these experienced seizures. By contrast, six (54.5%) of the 11 N. G. Dan and M. J. Wade patients with a frontal catheter site became epileptic. The only patient with both frontal and parietal catheterization developed seizures. All six of the 11 patients who had frontal catheterization and who experienced seizures had shunt revisions: two had one revision, three had two revisions, and one had three revisions. Unlike our experience with seizures following trauma or craniotomy, we were surprised to note that no convulsions occurred during the first 14 clays after shunting. However, 52.9% of those who developed seizures did so in the 1st year (Table 4 ). The notable exception was a man who had a shunt insertion and posterior fossa craniotomy for a cerebellar astrocytoma. Subsequently, he had three shunt revisions, and a subdural hematoma was evacuated after a head injury 2 years before his first grand mal seizure. He had also been treated with radiotherapy at the time of craniotomy. His first convulsion occurred 10 years after shunting.
Prophylactic anticonvulsant therapy was used in 21 patients (Table 5) . These included eight patients with meningitis or encephalitis, of whom one developed seizures; five with subarachnoid hemorrhage, of whom two subsequently had seizures; and seven patients with tumors, of whom two developed seizures. Two of these five patients had their first convulsion only after withdrawal of the prophylactic anticonvulsant drugs.
Discussion
A 9.4% incidence of epilepsy after ventricular shunting is a notable occurrence, but it is lower than reported in other series, z4'7 We found an apparedtly lower incidence in older age groups but this was not of statistical Epilepsy following ventricular shunts 2 reported an increased risk of postoperative epilepsy in the presence of infection. We had no recognized cases of meningitis and were unable to accurately document minor wound infections from our records.
In this series, the remarkable incidence of seizures after frontal catheterization compared with that of posterior parietal catheterization was of statistical significance (p = 0.01). In the report of Boarini, et al., j concerning seizures in patients suffering from cerebral gliomas, there was no significant percentage difference for parietal (40%) and for frontal (37%) gliomas although the incidence was lower with tumors in other areas. Our findings suggest that the frontal locus should be avoided whenever practicable.
We remain unconvinced about the role of prophylactic anticonvulsant therapy, and note that two of the five patients in our series who received prophylactic drugs and still developed seizures first suffered seizures after withdrawal of the drugs. As long as debate continues regarding the use of prophylactic anticonvulsant drugs in craniotomies generally, it is likely that their use after shunting will also be in question. 8 We believe that the documented incidence of postshunt epilepsy constitutes an indication for the use of alternative CSF diversionary techniques, such as lumboperitoneal shunting, when they are clinically appropriate.
